Schedule 13G ownership disclosure

Syndax Pharmaceuticals Inc

Common Stock, par value $0.0001 per share · CUSIP: 87164F105

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Kynam Capital Management, LP

    Shares: 8,520,000 · Class: 9.98%

  • Kynam Capital Management GP, LLC

    Shares: 8,520,000 · Class: 9.98%

  • Yue Tang

    Shares: 8,520,000 · Class: 9.98%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-25-001726
Form type
SCHEDULE 13G/A
Filer
Kynam Capital Management, LP
CIK
CIK 1907884
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub